Hologen AI is a pioneering company specializing in the application of generative artificial intelligence (AI) to healthcare, particularly in neurology and neuroimaging. Their mission is to enhance patient outcomes by integrating advanced AI technologies into medical research and clinical practices.
Key Features of Hologen AI:
- Hologen AI develops large medical models (LMMs) that learn the rich biological diversity of healthy and pathological variations. These models capture complex biological heterogeneity with high fidelity, enabling accurate quantification of therapeutic effects and revealing disease mechanisms that may be opaque to conventional models.
- By combining AI with clinical medicine, Hologen AI aims to transform the discovery and development of therapies targeting central nervous system (CNS) circuitry in neurodegenerative and neuropsychiatric disorders.
Use Cases:
- Hologen AI has entered into a strategic collaboration with MeiraGTx to expedite the development of AAV-GAD, a gene therapy for Parkinson’s disease. This partnership leverages Hologen’s AI to elucidate brain circuitry, significantly de-risking the Phase 3 program and identifying disease-modifying changes in response to treatment.
